News headlines about Healthways (NASDAQ:TVTY) have been trending somewhat positive on Saturday, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Healthways earned a daily sentiment score of 0.05 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.8114828108693 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the media headlines that may have impacted Accern’s analysis:
- Tivity Health Announces National SilverSneakers® Richard L. Swanson Award Winner (finance.yahoo.com)
- Tivity Health, Inc. breached its 50 day moving average in a Bullish Manner : TVTY-US : August 7, 2017 (finance.yahoo.com)
- Healthways, Inc. (NASDAQ:TVTY) Insider Sells $801,990.00 in Stock (americanbankingnews.com)
Shares of Healthways (NASDAQ TVTY) traded down 1.21% on Friday, hitting $36.85. The company had a trading volume of 298,849 shares. The firm has a 50-day moving average price of $39.29 and a 200 day moving average price of $32.55. The company has a market capitalization of $1.45 billion, a P/E ratio of 16.60 and a beta of 0.37. Healthways has a 12-month low of $19.25 and a 12-month high of $41.55.
Healthways (NASDAQ:TVTY) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.41 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.03. The business had revenue of $138.90 million during the quarter, compared to analysts’ expectations of $138.15 million. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The firm’s revenue was up 11.1% on a year-over-year basis. Equities analysts expect that Healthways will post $1.52 EPS for the current year.
Several research firms recently weighed in on TVTY. Zacks Investment Research lowered Healthways from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. UBS AG boosted their target price on Healthways from $37.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, June 23rd. Barrington Research boosted their target price on Healthways from $35.00 to $44.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Cantor Fitzgerald boosted their target price on Healthways from $34.00 to $42.00 and gave the stock an “overweight” rating in a report on Friday, June 9th. Finally, BidaskClub upgraded Healthways from a “buy” rating to a “strong-buy” rating in a report on Friday, June 9th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $38.25.
ILLEGAL ACTIVITY WARNING: This story was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://stocknewstimes.com/2017/08/13/healthways-tvty-earning-somewhat-favorable-press-coverage-study-finds.html.
In other Healthways news, Director Conan Laughlin sold 1,750,000 shares of Healthways stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total value of $66,325,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Glenn Hargreaves sold 21,105 shares of Healthways stock in a transaction on Friday, August 4th. The shares were sold at an average price of $38.00, for a total value of $801,990.00. Following the completion of the transaction, the insider now directly owns 59,077 shares of the company’s stock, valued at $2,244,926. The disclosure for this sale can be found here. Company insiders own 8.42% of the company’s stock.
Healthways Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
